Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Crospon, Ltd. — Predicate Candidate Screening

12 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

107 daysmedian FDA review time
148 days90th percentile
12clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K183072EndoFLIP SystemCrospon, Ltd.2019-02-151021
K172128EsoFLIP® ES-310 Balloon CatheterCrospon, Ltd.2017-11-221310
K170833EndoFLIP® System with FLIP Topography moduleCrospon, Ltd.2017-04-17280
K160725EndoFLIPCrospon, Ltd.2016-05-01460
K142000ESOFLIP ESCrospon, Ltd.2014-09-25640
K132337ESOFLIP BALLOON DILATION CATHETERCrospon, Ltd.2013-10-07731
K130906ENDOFLIP CATHETERCrospon, Ltd.2013-07-171070
K120997BAROSTAT SOFTWARE OPTIONCrospon, Ltd.2012-08-271470
K110531ENDOFLIP ECDCrospon, Ltd.2011-10-062240
K110529ENDOFLIP GASTRIC TUBECrospon, Ltd.2011-07-221480
K102214ENDO FLIPCrospon, Ltd.2010-12-161320
K092850ENDOFLIPCrospon, Ltd.2009-12-15900

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda